메뉴 건너뛰기




Volumn 11, Issue 2, 1999, Pages 691-699

Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes

Author keywords

Cannabinoids; CP 55940; Glial cells; SR 141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PERTUSSIS TOXIN; POLYCLONAL ANTIBODY; RECEPTOR; RECEPTOR ANTIBODY; RIMONABANT;

EID: 0033047698     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00480.x     Document Type: Article
Times cited : (85)

References (3)
  • 2
    • 0031935011 scopus 로고    scopus 로고
    • Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
    • Adams, I.B., Compton, D.R. & Martin, B.R. (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Phannacol. Exp. Ther., 284, 1209-1217.
    • (1998) J. Phannacol. Exp. Ther. , vol.284 , pp. 1209-1217
    • Adams, I.B.1    Compton, D.R.2    Martin, B.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.